Effects of Different Oxytocin Infusions on Blood Loss and Postpartum Hemoglobin Values in Patients Undergoing Elective Cesarean Delivery

Although prior dose-finding studies have investigated the optimal bolus dose of oxytocin to initiate adequate uterine tone, it is unclear what oxytocin infusion regimen is required to maintain adequate uterine tone after delivery. The study investigators aim to compare two different infusion rates of oxytocin to assess the optimal infusion regimen for reducing blood loss in women undergoing elective Cesarean delivery.

Stanford is now accepting new patients for this trial. Please contact Alexander J Butwick, F.R.C.A at 650-736-8513 for more information.



  • drug : Oxytocin Infusion

Phase: Phase 3


Ages Eligible For Study:

18 Years - 40 Years

Inclusion Criteria

- Healthy pregnant patients with uncomplicated pregnancies: - ASA (American Association of Anesthesiologists) class 1 or 2 patients. - Singleton pregnancies.

External Links

Explore related trials

Contact information

Primary Contact:

Alexander J Butwick, F.R.C.A 650-736-8513

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: